创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Action Mechanism and Application Progress of Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia
XIA Yi, XU Wei
2022, 46(6): 403-411.
Abstract PDF
Progress in Drug Research for Non-Hodgkin’s Lymphoma
CHEN Xiaoli, YU Hui, KONG Xiangtu, NI Haiwen
2022, 46(6): 412-426.
Abstract PDF
Advances in Immunotherapy for Multiple Myeloma
NI Ying, LI Ping, LIANG Aibin
2022, 46(6): 427-434.
Abstract PDF
Current Development of Novel Agents for Multiple Myeloma
LU Jing, DU Juan
2022, 46(6): 435-446.
Abstract PDF
Progress of B Cell Lymphoma 2 Inhibitors in the Treatment of Myelodysplastic Syndrome
SONG Luxi, CHANG Chunkang
2022, 46(6): 447-454.
Abstract PDF
Recent Advances of Novel Agents in Clinical Research on Acute Myeloid Leukemia
MA Jiale, GE Zheng
2022, 46(6): 455-470.
Abstract PDF
Progress of Research on Drug Targets in China (I)
JIANG Zhenzhou, FAN Shusheng, LIU Jiaqi, YU Qinwei, ZHANG Luyong
2022, 46(6): 471-494.
Abstract PDF